Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03783013 · ClinicalTrials.gov registry record · NA
Tomato Juice for Health Study
A NA study, sponsored by USDA Beltsville Human Nutrition Research Center.
- Terminated
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT03783013: Clinical Trial NA study, sponsored by USDA Beltsville Human Nutrition Research Center.
NCT03783013 is a NA study that was terminated before completion, run by USDA Beltsville Human Nutrition Research Center. The registered enrollment target is 19 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03783013, a NA study, was terminated before completion, sponsored by USDA Beltsville Human Nutrition Research Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
The primary objective of this study is to determine if tomato-soy juice can reduce inflammation, which is linked to chronic disease
Primary Outcome
Interleukin 6 (IL6) is a blood cytokine and an indicator of inflammatory status. IL6 will be measured to determine how the treatment is affecting inflammatory status. Cytokines are measured in units of pg/mL.
Interventions
- OTHER High Lycopene Tomato Juice With Soy Germ Extract
- OTHER Low Lycopene Tomato Juice
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2019-01-08 |
| Est. Completion | 2021-08-25 |
| Phase | NA |
Why NCT03783013 stopped before completion
NCT03783013 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which High Lycopene Tomato Juice With Soy Germ Extract is the first listed.
NCT03783013 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03783013 about?
NCT03783013 is a clinical study titled "Tomato Juice for Health Study". The primary objective of this study is to determine if tomato-soy juice can reduce inflammation, which is linked to chronic disease
What is the current status of trial NCT03783013?
This trial is currently terminated. It is a NA study. The enrollment target is 19 participants. The study started on 2019-01-08. Estimated completion is 2021-08-25.
What interventions are being tested in trial NCT03783013?
The interventions under investigation include: High Lycopene Tomato Juice With Soy Germ Extract (OTHER), Low Lycopene Tomato Juice (OTHER).
Who is sponsoring clinical trial NCT03783013?
This trial is sponsored by USDA Beltsville Human Nutrition Research Center, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03783013's enrollment target sits among peer trials
19 1861st of 2000 higher than 138 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI